levetiracetam in sodium chloride
Generic: levetiracetam
Labeler: nexus pharmaceuticals llcDrug Facts
Product Profile
Brand Name
levetiracetam in sodium chloride
Generic Name
levetiracetam
Labeler
nexus pharmaceuticals llc
Dosage Form
INJECTION
Routes
Active Ingredients
levetiracetam 15 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
14789-330
Product ID
14789-330_a8f5d5d3-7659-4b56-895c-d1f9c3e81973
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA213532
Listing Expiration
2026-12-31
Marketing Start
2020-07-20
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
14789330
Hyphenated Format
14789-330
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
levetiracetam in sodium chloride (source: ndc)
Generic Name
levetiracetam (source: ndc)
Application Number
ANDA213532 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 15 mg/mL
Packaging
- 10 BAG in 1 CARTON (14789-330-15) / 100 mL in 1 BAG (14789-330-08)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "a8f5d5d3-7659-4b56-895c-d1f9c3e81973", "openfda": {"nui": ["N0000008486"], "upc": ["0314789330150", "0314789110080", "0314789330082", "0314789220086"], "unii": ["44YRR34555"], "rxcui": ["1193358", "1193360", "1193362"], "spl_set_id": ["ee014183-a857-457b-9573-0cc168e560f3"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Nexus Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BAG in 1 CARTON (14789-330-15) / 100 mL in 1 BAG (14789-330-08)", "package_ndc": "14789-330-15", "marketing_start_date": "20200720"}], "brand_name": "Levetiracetam in Sodium Chloride", "product_id": "14789-330_a8f5d5d3-7659-4b56-895c-d1f9c3e81973", "dosage_form": "INJECTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "14789-330", "generic_name": "Levetiracetam", "labeler_name": "Nexus Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam in Sodium Chloride", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "15 mg/mL"}], "application_number": "ANDA213532", "marketing_category": "ANDA", "marketing_start_date": "20200720", "listing_expiration_date": "20261231"}